Tempus AI Total Assets 2023-2025 | TEM
- Tempus AI total assets for the quarter ending March 31, 2025 were $1.543B, a 228.84% increase year-over-year.
- Tempus AI total assets for 2024 were $0.926B, a 64.19% increase from 2023.
- Tempus AI total assets for 2023 were $0.564B, a 10.66% decline from 2022.
- Tempus AI total assets for 2022 were $0.631B, a 0% decline from .
Tempus AI Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $926 |
2023 | $564 |
2022 | $631 |
Tempus AI Quarterly Total Assets (Millions of US $) |
|
---|---|
2025-03-31 | $1,543 |
2024-12-31 | $926 |
2024-09-30 | $972 |
2024-06-30 | $865 |
2024-03-31 | $469 |
2023-12-31 | $564 |
2023-09-30 | $0 |
2023-06-30 | $0 |
2023-03-31 | $0 |
2022-12-31 | $631 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $11.403B | $0.693B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.731B | 53.50 |
Hims & Hers Health (HIMS) | United States | $11.944B | 124.09 |
IRhythm Technologies (IRTC) | United States | $4.673B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.222B | 65.97 |
Privia Health (PRVA) | United States | $2.843B | 194.33 |
Enovis (ENOV) | United States | $1.910B | 10.65 |
Clover Health Investments (CLOV) | United States | $1.634B | 0.00 |
Schrodinger (SDGR) | United States | $1.578B | 0.00 |
Phreesia (PHR) | United States | $1.484B | 0.00 |
Omnicell (OMCL) | United States | $1.387B | 24.47 |
Azenta (AZTA) | United States | $1.269B | 58.98 |
10x Genomics (TXG) | United States | $1.058B | 0.00 |
Butterfly Network (BFLY) | United States | $0.626B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
Talkspace (TALK) | United States | $0.494B | 147.50 |
Veradigm (MDRX) | United States | $0.460B | 0.00 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.391B | 0.00 |
TruBridge (TBRG) | United States | $0.361B | 801.00 |
Outset Medical (OM) | United States | $0.333B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
Health Catalyst (HCAT) | United States | $0.263B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.134B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
Pulmonx (LUNG) | United States | $0.124B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
CareCloud (CCLD) | United States | $0.087B | 3.32 |
111 (YI) | China | $0.069B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.024B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
HeartSciences (HSCS) | United States | $0.005B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |